Ryo Momosaki
Biographic Data
| ID | 7859865 |
|---|---|
| NAME | Ryo Momosaki |
| GIVEN NAMES | Ryo |
| FAMILY NAME | Momosaki |
| SIGNATURE | MOMOSAKI R |
| AFFILIATIONS | Mie University |
| ORCID | 0000-0003-3274-3952 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Acute‐Phase Interventions and Clinical Implementation Challenges for Hospital‐Associated Sarcopenia
Hospital‐associated sarcopenia (HAS) is a preventable and reversible condition characterized by rapid muscle loss during hospitalization. Although its prevalence is higher than that of age‐related sarcopenia, the clinical recognition and structured management of this condition remain limited. In this narrative review, the pathophysiology of HAS is synthesized, the effectiveness of acute‐phase interventions is evaluated, and the implementation cha…
Hq5
M.A. has disclosed financial relationships with Daiichi Sankyo Co. Ltd., MSD K.K. Toa Eiyo Co. Ltd., Towa Pharmaceutical Co. Ltd., Eisai Co. Ltd., Kracie Pharmaceutical Co. Ltd., Tsumura Pharmaceutical Co. Ltd., Tanabe Mitsubishi Pharma Corporation, Chugai Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., Bayer Yakuhin Ltd.
Response to the Letter by Chen et al. on “From Prognostic Marker to Therapeutic Target—Appetite in Swallowing Rehabilitation”
Research data are not shared.
Hq2
Conditions such as coronary artery disease, osteoarthritis, and cancer and its treatments are considered high risk for the onset of frailty, which may worsen disease responsiveness, activities of daily living (ADL), and life prognosis. Therefore, prevention of frailty in non-older adults at high risk holds significant individual and societal value. However, the evidence remains insufficient regarding whether digital health service interventions s…
Association between Japanese Diet Adherence and Muscle Weakness in Japanese Adults Aged ≥50 Years
Japanese diet adherence has been inversely correlated with muscle weakness. In this study, we aimed to validate that association. Longitudinal data from 1699 individuals aged ≥50 years (mean age 62.5 ± 6.9 years, 50.4% female) at two time points (2007 and 2011) were used. Participants without muscle weakness from several regions in Japan were included. The 12-component revised Japanese Diet Index (rJDI12) classified by tertiles assessed adherence…
Association of Japanese and Mediterranean Dietary Patterns with Muscle Weakness in Japanese Community-Dwelling Middle-Aged and Older Adults
The association of Japanese and Mediterranean dietary patterns with muscle weakness in middle-aged and older Japanese individuals is unclear. This cross-sectional study investigated the association between Japanese and Mediterranean dietary patterns and muscle weakness in community-dwelling, middle-aged, and older Japanese individuals (enrolled from 2007 to 2011). Based on the dietary consumption information obtained from the brief self-administe…
No prominent works on this page.
Association of Japanese and Mediterranean Dietary Patterns with Muscle Weakness in Japanese Community-Dwelling Middle-Aged and Older Adults
The association of Japanese and Mediterranean dietary patterns with muscle weakness in middle-aged and older Japanese individuals is unclear. This cross-sectional study investigated the association between Japanese and Mediterranean dietary patterns and muscle weakness in community-dwelling, middle-aged, and older Japanese individuals (enrolled from 2007 to 2011). Based on the dietary consumption information obtained from the brief self-administe…
Association between Japanese Diet Adherence and Muscle Weakness in Japanese Adults Aged ≥50 Years
Japanese diet adherence has been inversely correlated with muscle weakness. In this study, we aimed to validate that association. Longitudinal data from 1699 individuals aged ≥50 years (mean age 62.5 ± 6.9 years, 50.4% female) at two time points (2007 and 2011) were used. Participants without muscle weakness from several regions in Japan were included. The 12-component revised Japanese Diet Index (rJDI12) classified by tertiles assessed adherence…
Acute‐Phase Interventions and Clinical Implementation Challenges for Hospital‐Associated Sarcopenia
Hospital‐associated sarcopenia (HAS) is a preventable and reversible condition characterized by rapid muscle loss during hospitalization. Although its prevalence is higher than that of age‐related sarcopenia, the clinical recognition and structured management of this condition remain limited. In this narrative review, the pathophysiology of HAS is synthesized, the effectiveness of acute‐phase interventions is evaluated, and the implementation cha…
Hq5
M.A. has disclosed financial relationships with Daiichi Sankyo Co. Ltd., MSD K.K. Toa Eiyo Co. Ltd., Towa Pharmaceutical Co. Ltd., Eisai Co. Ltd., Kracie Pharmaceutical Co. Ltd., Tsumura Pharmaceutical Co. Ltd., Tanabe Mitsubishi Pharma Corporation, Chugai Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., Bayer Yakuhin Ltd.
Response to the Letter by Chen et al. on “From Prognostic Marker to Therapeutic Target—Appetite in Swallowing Rehabilitation”
Research data are not shared.
Hq2
Conditions such as coronary artery disease, osteoarthritis, and cancer and its treatments are considered high risk for the onset of frailty, which may worsen disease responsiveness, activities of daily living (ADL), and life prognosis. Therefore, prevention of frailty in non-older adults at high risk holds significant individual and societal value. However, the evidence remains insufficient regarding whether digital health service interventions s…
Nutrition and Health in Aging (5 works) · Frailty in Older Adults (3 works) · Confidence interval (2 works) · Demography (2 works) · Demography (2 works) · Digital health (2 works) · Environmental health (2 works) · Gerontology (2 works) · Guideline (2 works) · Internal Medicine (2 works)